An Adolescent with Kleptomania and Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate

被引：2
|
作者：
Herguner, Sabri [1 ]
Tanidir, Canan [1 ]
机构：
[1] Bakirko State Hosp Mental Hlth & Neurol Disorders, Child & Adolescent Psychiat Clin, TR-42080 Istanbul, Turkey
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2011年 / 21卷 / 04期
关键词：
COMORBIDITY;
D O I：
10.1089/cap.2010.0155
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：383 / 384
页数：2
相关论文
共 50 条
  • [31] HEMISPHERIC PROCESSING AND METHYLPHENIDATE EFFECTS IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    MALONE, MA
    KERSHNER, JR
    SWANSON, JM
    JOURNAL OF CHILD NEUROLOGY, 1994, 9 (02) : 181 - 189
  • [32] Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment
    Kara, Tayfun
    Akaltun, Ismail
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 484 - 484
  • [33] Methylphenidate transdermal system for the treatment of attention-deficit/hyperactivity disorder
    Rugino, Thomas
    FUTURE NEUROLOGY, 2007, 2 (06) : 613 - 620
  • [34] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
    Rafał R. Jaeschke
    Ewelina Sujkowska
    Magdalena Sowa-Kućma
    Psychopharmacology, 2021, 238 : 2667 - 2691
  • [35] THE EFFECT OF METHYLPHENIDATE ON OCULAR MOVEMENTS IN THE ATTENTION-DEFICIT DISORDER WITH HYPERACTIVITY
    BLONDIS, TA
    SHAPIRO, BK
    CAPUTE, AJ
    ZEE, DS
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1987, 8 (03): : 177 - 177
  • [36] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Mandali, Alekhya
    Sethi, Arjun
    Cercignani, Mara
    Harrison, Neil A.
    Voon, Valerie
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [37] Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
    Sugrue, David
    Bogner, Robin
    Ehret, Megan J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (14) : 1163 - 1170
  • [38] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Alekhya Mandali
    Arjun Sethi
    Mara Cercignani
    Neil A. Harrison
    Valerie Voon
    Translational Psychiatry, 11
  • [39] An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/hyperactivity disorder
    Froelich, Jan
    Banaschewski, Tobias
    Doepfner, Manfred
    Goertz-Dorten, Anja
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1169 - 1183
  • [40] Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate
    Wolraich, ML
    Doffing, MA
    CNS DRUGS, 2004, 18 (04) : 243 - 250
12345